CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis
Measurement of Neutrophil Membrane CD64 as an Early Indication of Neonatal Infection and Necrotising Enterocolitis (NEC).
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
A observational or N/A phase clinical study on Enterocolitis, Necrotizing and Neonatal SEPSIS, this trial is completed. The trial is conducted by Newcastle-upon-Tyne Hospitals NHS Trust and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 2 earlier versions
-
May 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — May 2017 [monthly]
Unknown Status NA
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Newcastle-upon-Tyne Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .